The concern about whether an active Shingles infection might interfere with a COVID-19 test is a logical one, given that both are viral illnesses. Shingles, caused by the Varicella-Zoster Virus (VZV), represents the reactivation of a virus that establishes lifelong latency in the body. The tests used to detect a current SARS-CoV-2 infection, the virus responsible for COVID-19, rely on highly advanced molecular technologies that are built for specificity. Fortunately, VZV does not cause a false positive result on standard COVID-19 diagnostic tests.
Specificity of VZV and SARS-CoV-2 Testing
The definitive answer is that a Shingles outbreak will not lead to a false positive result on either a molecular or an antigen COVID-19 test. This reliability stems from the fundamental biological differences between the two viruses and the precision of the testing technology. VZV and SARS-CoV-2 belong to completely different viral families, which is the primary reason cross-reactivity is not a concern.
VZV is a large, double-stranded DNA virus belonging to the Herpesviridae family, while SARS-CoV-2 is a single-stranded RNA virus of the Coronaviridae family. Diagnostic tests are designed to recognize unique signatures specific to SARS-CoV-2, effectively ignoring material from other viruses. The vast genetic and structural differences between VZV and SARS-CoV-2 mean that the parts of the viruses detected by the tests do not match.
How COVID Detection Methods Work
COVID-19 diagnostic testing relies on two main methods: molecular tests, such as Reverse Transcription-Polymerase Chain Reaction (RT-PCR), and rapid antigen tests. Each method targets distinct and exclusive components of the SARS-CoV-2 virus. Molecular tests amplify specific genetic sequences, while antigen tests detect unique surface proteins.
The RT-PCR method works by using highly specific genetic probes called primers. These primers are designed to bind only to specific target genes on the SARS-CoV-2 RNA genome, such as the N (Nucleocapsid), E (Envelope), or RdRp (RNA-dependent RNA polymerase) genes. Since VZV contains DNA, and its genetic code does not match the SARS-CoV-2 RNA sequences, the primers cannot bind to or amplify the VZV genetic material.
Rapid antigen tests operate on a “lock and key” principle. They use antibodies embedded on a test strip to capture specific proteins unique to the SARS-CoV-2 virus, most commonly the Nucleocapsid protein. The structural shape of the VZV proteins is entirely different and does not fit the antibody “locks” designed to recognize the SARS-CoV-2 “key.” This ensures that even if VZV is present in the sample, it will not trigger a positive result.
Immune Status and Co-infection Risk
While Shingles does not cause a false positive COVID-19 test, the presence of an active VZV infection highlights a relevant health connection through the immune system. A Shingles outbreak occurs when the dormant VZV reactivates, which typically happens when a person’s cell-mediated immunity is temporarily weakened. The immune system, particularly T-cells, usually keeps VZV in check.
A compromised immune state, indicated by VZV reactivation, suggests the body is under stress and might be less equipped to handle a new infection. This temporary immune burden could increase susceptibility to contracting SARS-CoV-2 or lead to a more intense course of COVID-19.
Studies have observed cases of VZV reactivation following a COVID-19 infection, suggesting that the body’s response to SARS-CoV-2 can suppress the immune system enough to allow Shingles to emerge. The appearance of Shingles is a signal of immune perturbation. Clinicians often consider the presence of Shingles as an indication that the patient’s immune defenses may be temporarily strained.